Industries
|
Companies
|
Filings
|
News
|
CaseLaw
|
Annual Reports
|
UK
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Latest 424B1 SEC Filings
Prospectus [Rule 424(b)(1)]
NPS PHARMACEUTICALS INC, 424B1, 2000-11-13
ONYX PHARMACEUTICALS INC, 424B1, 2000-07-19
CORIXA CORP, 424B1, 2000-04-10
BIOPURE CORP, 424B1, 2000-03-14
GILEAD SCIENCES INC, 424B1, 1999-10-29
MAGAININ PHARMACEUTICALS INC, 424B1, 1999-10-18
BIOTIME INC, 424B1, 1999-02-17
ABGENIX INC, 424B1, 1998-07-02
MAGAININ PHARMACEUTICALS INC, 424B1, 1998-04-21
ANIKA THERAPEUTICS INC, 424B1, 1997-11-25
TEXAS BIOTECHNOLOGY CORP /DE/, 424B1, 1997-09-26
TRANSCEND THERAPEUTICS INC, 424B1, 1997-07-07
HESKA CORP, 424B1, 1997-07-01
MAGAININ PHARMACEUTICALS INC, 424B1, 1997-05-09
SPARTA PHARMACEUTICALS INC, 424B1, 1996-11-01
MAGAININ PHARMACEUTICALS INC, 424B1, 1996-10-31
ANERGEN INC, 424B1, 1996-08-12
GENZYME TRANSGENICS CORP, 424B1, 1996-08-01
CREATIVE BIOMOLECULES INC, 424B1, 1996-07-03
NEUROCRINE BIOSCIENCES INC, 424B1, 1996-05-24
ADVANCED TISSUE SCIENCES INC, 424B1, 1996-03-21
NORTH AMERICAN BIOLOGICALS INC, 424B1, 1995-10-30
LIFECORE BIOMEDICAL INC, 424B1, 1995-10-13
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
